Nutrient scavenging-fueled growth in pancreatic cancer depends on caveolae-mediated endocytosis under nutrient-deprived conditions.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
Mar 2024
Historique:
medline: 1 3 2024
pubmed: 1 3 2024
entrez: 1 3 2024
Statut: ppublish

Résumé

Pancreatic ductal adenocarcinoma (PDAC) is characterized by its nutrient-scavenging ability, crucial for tumor progression. Here, we investigated the roles of caveolae-mediated endocytosis (CME) in PDAC progression. Analysis of patient data across diverse datasets revealed a strong association of high caveolin-1 (Cav-1) expression with higher histologic grade, the most aggressive PDAC molecular subtypes, and worse clinical outcomes. Cav-1 loss markedly promoted longer overall and tumor-free survival in a genetically engineered mouse model. Cav-1-deficient tumor cell lines exhibited significantly reduced proliferation, particularly under low nutrient conditions. Supplementing cells with albumin rescued the growth of Cav-1-proficient PDAC cells, but not in Cav-1-deficient PDAC cells under low glutamine conditions. In addition, Cav-1 depletion led to significant metabolic defects, including decreased glycolytic and mitochondrial metabolism, and downstream protein translation signaling pathways. These findings highlight the crucial role of Cav-1 and CME in fueling pancreatic tumorigenesis, sustaining tumor growth, and promoting survival through nutrient scavenging.

Identifiants

pubmed: 38427741
doi: 10.1126/sciadv.adj3551
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadj3551

Auteurs

Adam R Wolfe (AR)

Department of Radiation Oncology, The University of Arkansas for Medical Sciences, The Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, USA.

Tiantian Cui (T)

Department of Radiation Oncology, City of Hope, Duarte, CA, USA.

Sooin Baie (S)

Department of Cancer Biology and Genetics, The Ohio State University Wexner Medical Center, Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, Columbus, OH, USA.

Sergio Corrales-Guerrero (S)

Department of Radiation Oncology, City of Hope, Duarte, CA, USA.

Amy Webb (A)

Department of Biomedical Informatics, The Ohio State University, Columbus, OH, USA.

Veronica Castro-Aceituno (V)

Department of Radiation Oncology, City of Hope, Duarte, CA, USA.

Duan-Liang Shyu (DL)

Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, Columbus, OH, USA.

Joanna M Karasinska (JM)

Pancreas Centre BC, Vancouver, BC, Canada.

James T Topham (JT)

Pancreas Centre BC, Vancouver, BC, Canada.

Daniel J Renouf (DJ)

Pancreas Centre BC, Vancouver, BC, Canada.
Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.

David F Schaeffer (DF)

Pancreas Centre BC, Vancouver, BC, Canada.
Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, BC, Canada.

Megan Halloran (M)

Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, Columbus, OH, USA.

Rebecca Packard (R)

Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, Columbus, OH, USA.

Ryan Robb (R)

Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Wei Chen (W)

Department of Pathology, The Ohio State University Wexner Medical Center, Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, Columbus, OH, USA.

Nicholas Denko (N)

Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, Columbus, OH, USA.

Michael Lisanti (M)

Translational Medicine, University of Salford, Greater Manchester M5 4WT, UK.
Lunella Biotech, Inc., 145 Richmond Road, Ottawa, ON K1Z 1A1, Canada.

Timothy C Thompson (TC)

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, USA.

Philippe Frank (P)

SGS France, Health & Nutrition, Saint-Benoît, France.
N2C, Nutrition Growth and Cancer, Faculté de Médecine, Université de Tours, Inserm, UMR, 1069 Tours, France.

Terence M Williams (TM)

Department of Radiation Oncology, City of Hope, Duarte, CA, USA.

Classifications MeSH